Human RECQ1 promotes restart of replication forks reversed by DNA topoisomerase I inhibition

Human RECQ1 promotes restart of replication forks reversed by DNA topoisomerase I inhibition

Topoisomerase I (TOP1) inhibitors are an important class of anticancer drugs. The cytotoxicity of TOP1 inhibitors can be modulated by replication fork reversal, in a process that requires PARP activity. Whether regressed forks can efficiently restart and the factors required to restart fork progress...

Full description

Bibliographic Details
Main Authors: Berti, Matteo, Chaudhuri, Arnab Ray, Thangavel, Saravanabhavan, Gomathinayagam, Shivasankari, Kenig, Sasa, Vujanovic, Marko, Odreman, Federico, Glatter, Timo, Graziano, Simona, Mendoza-Maldonado, Ramiro, Marino, Francesca, Lucic, Bojana, Biasin, Valentina, Gstaiger, Matthias, Aebersold, Ruedi, Sidorova, Julia M., Monnat, Raymond J., Lopes, Massimo, Vindigni, Alessandro
Format: Online
Language:English
Published: 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897332/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897332/

Similar Items